Sibopirdine

Sibopirdine, also known as EXP921, is a nootropic drug.[1]

Sibopirdine
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: unscheduled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H18N4
Molar mass350.425 g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

Synthesis

Sibopirdine synthesis: DuPont Merck Pharmaceutical Company; U.S. Patent 5,272,269 (1993).

4,5-Diazafluoren-9-one was the starting material.

gollark: Especially with a third dimension!
gollark: osmarks internet radio™
gollark: Nothing with centrism is a vertex, heavdronic being.
gollark: It's moderately okay™, citronoentity.
gollark: Of the political 5-cube, or what?

See also

References

  1. Wong YN, Quon CY, Holm KA, Burcham DL, Frey NL, Huang SM, Lam GN (February 1996). "Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats". Drug Metabolism and Disposition. 24 (2): 172–9. PMID 8742228.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.